Lifshitz Law PLLC Announces Investigations of Verra Mobility Corporation (NASDAQ: VRRM), Badger Meter, Inc. (NYSE: BMI), CommVault Systems, Inc. (NASDAQ: CVLT), and GeneDx Holdings Corp (NASDAQ: WGS)

By ACCESS Newswire

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2026 / Lifshitz Law Firm

Verra Mobility Corporation (NASDAQ:VRRM)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material adverse facts concerning the true state of Verra's relationship with Avis Budget Group ("Avis"), specifically in terms of obtaining a contract extension with Avis. The Company had previously assumed a successful renewal of the agreement as part of its financial outlook, explicitly communicating to investors during its Q1 earnings call on May 6, 2026, that it expected a formal resolution with Avis in the first half of the year. However, on May 26, 2026, Verra announced that Avis delivered a notice terminating its commercial services agreement, effective September 2026.

If you are a VRRM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Badger Meter, Inc. (NYSE:BMI)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company's reported strong financial results did not reflect "ongoing favorable industry trends," "secular growth drivers," or "solid operating execution," as represented, but were instead unsustainable; (ii) statements touting "strong" demand, "robust order pacing," and a "strong bid pipeline," overstated the true state of the Company's demand environment and ability to generate continued sales and earnings growth; and (iii) contrary to the Company's claims that Badger Meter possessed a "long runway" for growth, Badger Meter's growth prospects were materially overstated, such that the Company lacked a reasonable basis for their positive statements about Badger Meter's business, operations, and future prospects.

If you are a BMI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

CommVault Systems, Inc. (NASDAQ:CVLT)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company provided investors with misleading guidance and projections regarding CommVault's anticipated annual recurring revenue ("ARR") growth for fiscal year 2026, including projections related to new net ARR growth; (ii) the Company simultaneously disseminated overly positive statements while concealing material adverse facts concerning the true state of CommVault's ARR growth environment; (iii) the Company knew or recklessly disregarded that CommVault's ARR growth guidance failed to properly account for critical variables, including the type of sales driving ARR performance; and (iv) as a result of the foregoing, the Company's statements about CommVault's business, operations, and prospects lacked a reasonable basis and were materially false and misleading at all relevant times.

If you are a CVLT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

GeneDx Holdings Corp (NASDAQ:WGS)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company may have misled investors about the importance of Fabric Genomics; (ii) as a result, the Company's margins would suffer; (iii) the Company's average reimbursement rates were not as "durable" as previously disclosed; (iv) as a result of the foregoing, the Company's gross margins would decline; and (v) as a result of the foregoing, the Company's positive statements about GeneDx's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

If you are a WGS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law Firm



View the original press release on ACCESS Newswire

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.